Mary Pinder-Schenck, M.D.
Dr. Mary Pinder-Schenck joined the Moffitt team, coming from the Virginia Mason Medical Center in Seattle, Washington. Dr. Pinder-Schenck graduated from Stanford University, Stanford, CA and received her postgraduate training at the University of North Carolina, Chapel Hill, NC and University of Texas, MD Anderson Cancer Center, Houston TX.
Dr. Pinder-Schenck's clinical research is aimed at bringing novel agents and combinations into the clinic for patients with thoracic malignancies. She is also interested in uncovering clinical and molecular data which will allow clinicians to better tailor therapies to individual patients and tumors.
